Abstract
Following numerous reports of high histidine decarboxylase (HDC) activity in tumour-bearing animals, the present work was designed to determine the activity of this enzyme in normal and tumour tissues in a series of ten surgical patients with colorectal carcinoma.
Significantly increased HDC activity, almost double that of normal tissues, was found in specimens from extirpated human tumours. These results, obtained under reliable sampling and measurement conditions indicated that changes in the enzymic activity of HDC may have a significant role in the development of colorectal tumour cells. Inhibition of the enzyme activity in human cancer subjects may retard or impede tumour growth and perhaps limit the spread of metastases.
Similar content being viewed by others
References
D. Mackay, P. B. Marshall and J. F. Riley,Histidine decarboxylase activity in a malignant rat hepatoma, J. Physiol.31P, 153–156 (1960).
G. Kahlson and E. Rosengren,Histamine: entering physiology, Experientia20, 291–294 (1987).
H. Nolte, P. Stahl Skov and H. Loft,Stimulation of histamine synthesis from tumour cells by concanavalin A and A23187, Agents and Actions20, 291–294 (1987).
P. Scheinmann, B. Lebel, N. R. Lynch, J. C. Salomon, J. R. Paupe and C. Burtin,Histamine levels in blood and other tissues of male and female C 3H mice. II. Mice carrying a 3-methyl-cholanthrene-induced tumour, Agents and Actions9, 95–96 (1979).
C. Burtin, P. Scheinmann, K. C. Salamon, G. Lespinats and P. Canu,Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H 1 and H2 histamine receptors, Br. J. Cancer45, 54–60 (1982).
J. Bartholeyns and M. Bouclier,Involvement of histamine in growth of mouse and rat tumours; antitumoral properties of monofluoromethyl histamine, an enzyme-activated irreversible inhibitor of histidine decarboxylase, Cancer Research44, 639–645 (1984).
D. Kierska, K. Sasiak, T. Bieganski and Cz. Maslinski,Causal relationship between a tumour growth and the changes in histamine methabolism in tissues of sacroma-bearing rat, Agents and Actions20, 314–316 (1987).
M. Osband, Y.-J. Shen, M. Schlesinger, A. Brown, D. Hamilton, E. Cohen, P. Lavin and R. Mc Caffrey,Successful tumour immunotherapy with cimetidine in mice, Lanceti, 636–638 (1981).
A. J. Scolnick, M. C. Rubio, L. L. Colombo, R. R. Comoli and R. A. Caro,Further studies on the histamine metabolism in the M-2 adenocarcinoma. Biomedicine and Pharmacotherapy38, 465–467 (1984).
E. Neugebauer and W. Lorenz,A modified Schayer procedure for the estimation of histidine decarboxylase activity: its application on tissue extracts from gastric mucosa of various mammals. Agents and Actions12, 32–40 (1982).
J. Kusche, T. Bieganski, R. Hesterberg, C.-D. Stahlknecht, K.-D. Feußner, I. Stahlenberg and W. Lorenz,The influence of carcinoma growth on diamine oxidase activity in the human gastrointestinal tract, Agents and Actions10, 110–113 (1980).
Author information
Authors and Affiliations
Additional information
This paper is part of a joint project between the University of Malaga and the Philipps-University of Marburg.
Rights and permissions
About this article
Cite this article
Garcia-Caballero, M., Neugebauer, E., Campos, R. et al. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: Results of a study on ten patients. Agents and Actions 23, 357–360 (1988). https://doi.org/10.1007/BF02142587
Issue Date:
DOI: https://doi.org/10.1007/BF02142587